News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

International Stem Cell Corporation Subsidiary Lifeline Cell Technology, LLC Enters into Agreement with University of California to Study Macular Degeneration and Retinitis Pigmentosa



3/19/2007 12:48:05 PM

OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation, Inc. (OTCBB:ISCO) announced today that its wholly owned subsidiary, Lifeline Cell Technology, LLC, has entered into a research agreement with the Regents of the University of California for three studies, one of which is focused on stem cell therapy for the possible treatment of macular degeneration and retinitis pigmentosa.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES